Medical Device Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Medical Device Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

The global medical device testing market size reached US$ 11.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 17.5 Billion by 2028, exhibiting a growth rate (CAGR) of 6.6% during 2023-2028.

Medical device testing refers to the process of inspecting the design and production efficiency of various active and non-active medical equipment. It involves prototype, biocompatibility, chemistry, microbiology and sterility testing, package validation, electrical, mechanical and functional safety assessments and software testing. These tests are conducted for cardiovascular, neuro and orthopedic devices, dental implants and material components. The service providers also offer in-house or outsourced testing, inspection and certification services to the consumers. These services ensure that the device is reliable and safe to use in clinical or emergency settings. As a result, medical device testing finds extensive applications across hospitals, clinics and other healthcare and diagnostic centers.

Significant growth in the medical industry, along with the increasing requirement of validation and verification of medical devices, represents one of the key factors creating a positive outlook for the market. Moreover, as the coronavirus disease (COVID-19) continues to spread across the globe, there has been a significant increase in the demand for efficient testing systems to develop low-cost medical devices which is further augmenting the market growth. Additionally, various technological advancements, such as the utilization of artificial intelligence (AI), robotics and automation in the testing processes, are acting as other major growth-inducing factors. Device manufacturers use automated quality assurance tools to increase the accuracy of clinical equipment and wearable medical devices with minimal human intervention in the testing processes. Other factors, such as increasing complexities in product design, along with the widespread adoption of outsourced testing services, are anticipated to drive the market further.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global medical device testing market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on service, type, testing type, device class and device type.

Breakup by Service:

Testing Services
Inspection Services
Others

Breakup by Type:

In-House
Outsourced

Breakup by Testing Type:

Biocompatibility Testing
Chemistry Testing
Bio-Burden Determination
Anti-Microbial Activity and Sterility Testing
Others

Breakup by Device Class:

Class I
Class II
Class III

Breakup by Device Type:

Implantable Medical Devices
Non-Active Medical Devices
In-Vitro Diagnostic Medical Devices
Ophthalmic Medical Devices
Others

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being American Preclinical Services LLC, Charles River Laboratories International Inc., Element Materials Technology, Eurofins Scientific LLC, Intertek Group Plc, North American Science Associates Inc., Pace Analytical Services LLC (LAB Holdings Inc.), SGS SA, Sterigenics U.S. LLC (Sotera Health LLC), Toxikon Corporation, TÜV Rheinland Aktiengesellschaft, TÜV SÜD Aktiengesellschaft and WuXi AppTec.

Key Questions Answered in This Report:
How has the global medical device testing market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global medical device testing market?
What are the key regional markets?
What is the breakup of the market based on the service?
What is the breakup of the market based on the type?
What is the breakup of the market based on the testing type?
What is the breakup of the market based on the device class?
What is the breakup of the market based on the device type?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global medical device testing market and who are the key players?
What is the degree of competition in the industry?


1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Medical Device Testing Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Service
6.1 Testing Services
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Inspection Services
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Others
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Type
7.1 In-House
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Outsourced
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Testing Type
8.1 Biocompatibility Testing
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Chemistry Testing
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Bio-Burden Determination
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Anti-Microbial Activity and Sterility Testing
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by Device Class
9.1 Class I
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Class II
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Class III
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Device Type
10.1 Implantable Medical Devices
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Non-Active Medical Devices
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 In-Vitro Diagnostic Medical Devices
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Ophthalmic Medical Devices
10.4.1 Market Trends
10.4.2 Market Forecast
10.5 Others
10.5.1 Market Trends
10.5.2 Market Forecast
11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia-Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Price Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 American Preclinical Services LLC
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.2 Charles River Laboratories International Inc.
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.2.3 Financials
16.3.2.4 SWOT Analysis
16.3.3 Element Materials Technology
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.3.3 Financials
16.3.4 Eurofins Scientific LLC
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.5 Intertek Group Plc
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.5.3 Financials
16.3.5.4 SWOT Analysis
16.3.6 North American Science Associates Inc.
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.7 Pace Analytical Services LLC (LAB Holdings Inc.)
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.8 SGS SA
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.8.3 Financials
16.3.9 Sterigenics U.S. LLC (Sotera Health LLC)
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.10 Toxikon Corporation
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.11 TÜV Rheinland Aktiengesellschaft
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio
16.3.11.3 Financials
16.3.12 TÜV SÜD Aktiengesellschaft
16.3.12.1 Company Overview
16.3.12.2 Product Portfolio
16.3.12.3 Financials
16.3.13 WuXi AppTec
16.3.13.1 Company Overview
16.3.13.2 Product Portfolio
16.3.13.3 Financials

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings